JP7714571B2 - テルペンフェノール化合物およびそれらの使用 - Google Patents
テルペンフェノール化合物およびそれらの使用Info
- Publication number
- JP7714571B2 JP7714571B2 JP2022560311A JP2022560311A JP7714571B2 JP 7714571 B2 JP7714571 B2 JP 7714571B2 JP 2022560311 A JP2022560311 A JP 2022560311A JP 2022560311 A JP2022560311 A JP 2022560311A JP 7714571 B2 JP7714571 B2 JP 7714571B2
- Authority
- JP
- Japan
- Prior art keywords
- pet
- cbd
- compound
- pharmaceutically acceptable
- hydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/32—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions without formation of -OH groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/38—Alcohols containing six-membered aromatic rings and other rings and having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
- C07C37/003—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by hydrogenation of an unsaturated part
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/11—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
- C07C37/14—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by addition reactions, i.e. reactions involving at least one carbon-to-carbon unsaturated bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/15—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing six-membered aromatic rings and other rings, with unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003270P | 2020-03-31 | 2020-03-31 | |
| US63/003,270 | 2020-03-31 | ||
| PCT/GB2021/050812 WO2021198692A1 (en) | 2020-03-31 | 2021-03-31 | Terpenophenolic compounds and their use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520794A JP2023520794A (ja) | 2023-05-19 |
| JP2023520794A5 JP2023520794A5 (enExample) | 2024-04-11 |
| JP7714571B2 true JP7714571B2 (ja) | 2025-07-29 |
Family
ID=75426633
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560311A Active JP7714571B2 (ja) | 2020-03-31 | 2021-03-31 | テルペンフェノール化合物およびそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12552733B2 (enExample) |
| EP (1) | EP4126800A1 (enExample) |
| JP (1) | JP7714571B2 (enExample) |
| KR (1) | KR20230121960A (enExample) |
| CN (1) | CN116194431B (enExample) |
| AU (1) | AU2021248627A1 (enExample) |
| BR (1) | BR112022019616A2 (enExample) |
| GB (3) | GB2628746A (enExample) |
| IL (1) | IL296861A (enExample) |
| MX (1) | MX2022011832A (enExample) |
| WO (1) | WO2021198692A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3959193A4 (en) * | 2019-05-23 | 2022-07-13 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020041326A1 (en) | 2018-08-20 | 2020-02-27 | Berkowitz Barry A | Applications of known and novel cannabinoids |
| WO2020232545A1 (en) | 2019-05-23 | 2020-11-26 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL136839A (en) * | 2000-06-16 | 2006-12-10 | Yissum Res Dev Co | Pharmaceutical compositions comprising cannabidiol derivatives, and processes for the preparation of same |
| EP2578561A1 (en) | 2005-09-29 | 2013-04-10 | Albany Molecular Research, Inc. | Processes for the production of cannabidiol derivatives and intermediates thereof |
| AU2012201041B2 (en) * | 2005-09-29 | 2012-12-06 | Albany Molecular Research, Inc. | Process for production of delta-9-tetrahydrocannabinol |
| DK2176208T3 (en) * | 2007-07-30 | 2015-04-27 | Zynerba Pharmaceuticals Inc | Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof |
| DE102009019322A1 (de) | 2009-04-30 | 2010-11-11 | The Health Concept Gmbh | Verfahren zur Herstellung von Synthetischen Cannabinoiden |
| TWI583374B (zh) * | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| WO2014177593A1 (en) | 2013-04-29 | 2014-11-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Amorfrutin analogs as ppargamma-modulators |
| US9526706B1 (en) | 2015-06-16 | 2016-12-27 | Hong Kong Baptist University | Method of using dihydro-resveratrol for treating acute pancreatitis and associated pulmonary injury |
| US9738581B2 (en) * | 2015-06-16 | 2017-08-22 | Hong Kong Baptist University | Method of using dihydro-resveratrol or its stilbenoid derivatives and/or chemical variants in treatments of fibrotic and diabetic conditions |
| US20170008869A1 (en) * | 2015-07-10 | 2017-01-12 | Noramco, Inc. | Process for the production of cannabidiol and delta-9-tetrahydrocannabinol |
| CN109311838A (zh) | 2016-04-15 | 2019-02-05 | 蒂温诺特技术有限公司 | 大麻素前药的生物合成 |
| US20170362195A1 (en) | 2016-06-16 | 2017-12-21 | Full Spectrum Laboratories Ltd | Methods for the manufacture of cannabinoid prodrugs, pharmaceutical formulations and their use |
| US10640482B2 (en) | 2017-07-21 | 2020-05-05 | University Of South Florida | Synthesis of cannabinoids |
| CN111372907A (zh) | 2017-09-01 | 2020-07-03 | 普优峰全球股份有限公司 | 合成大麻二酚组合物和用于制备其的方法 |
| DE102017008367B4 (de) * | 2017-09-06 | 2019-06-13 | Sumitomo Wiring Systems, Ltd. | Abschirmverbinder und Verfahren zum Zusammenbauen desselben |
| CA3150642A1 (en) * | 2019-09-09 | 2021-03-18 | Kamaluddin Abdur-Rashid | CANNABINOID DERIVATIVES, PRECURSORS AND USES |
| CA3150646A1 (en) * | 2019-09-10 | 2021-03-18 | Kamaluddin Abdur-Rashid | CANNABINOID DERIVATIVES AND PRECURSORS, AND ASYMMETRICAL SYNTHESIS THEREOF |
-
2021
- 2021-03-31 CN CN202180038597.7A patent/CN116194431B/zh active Active
- 2021-03-31 GB GB2410277.4A patent/GB2628746A/en not_active Withdrawn
- 2021-03-31 MX MX2022011832A patent/MX2022011832A/es unknown
- 2021-03-31 JP JP2022560311A patent/JP7714571B2/ja active Active
- 2021-03-31 GB GB2104690.9A patent/GB2595355A/en not_active Withdrawn
- 2021-03-31 EP EP21717177.6A patent/EP4126800A1/en active Pending
- 2021-03-31 KR KR1020227037909A patent/KR20230121960A/ko active Pending
- 2021-03-31 WO PCT/GB2021/050812 patent/WO2021198692A1/en not_active Ceased
- 2021-03-31 BR BR112022019616A patent/BR112022019616A2/pt unknown
- 2021-03-31 AU AU2021248627A patent/AU2021248627A1/en active Pending
- 2021-03-31 GB GB2215746.5A patent/GB2609814B/en active Active
- 2021-03-31 US US17/916,494 patent/US12552733B2/en active Active
- 2021-03-31 IL IL296861A patent/IL296861A/en unknown
-
2022
- 2022-09-30 US US17/958,083 patent/US20230225985A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020041326A1 (en) | 2018-08-20 | 2020-02-27 | Berkowitz Barry A | Applications of known and novel cannabinoids |
| WO2020232545A1 (en) | 2019-05-23 | 2020-11-26 | Kare Chemical Technologies Inc. | Catalytic cannabinoid processes and precursors |
Non-Patent Citations (1)
| Title |
|---|
| CROMBIE, Leslie W. et al.，Synthesis of bibenzyl Cannabinoids, Hybrids of Two Biogenetic Series Found in Cannabis sativa，Journal of the Chemical Society, Perkin Transaction 1，1988年，no.5，pp.1263-1270 |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2609814A (en) | 2023-02-15 |
| MX2022011832A (es) | 2023-03-03 |
| GB2595355A (en) | 2021-11-24 |
| WO2021198692A1 (en) | 2021-10-07 |
| CN116194431B (zh) | 2026-01-02 |
| CA3177186A1 (en) | 2021-10-07 |
| IL296861A (en) | 2022-11-01 |
| CN116194431A (zh) | 2023-05-30 |
| AU2021248627A1 (en) | 2022-12-01 |
| EP4126800A1 (en) | 2023-02-08 |
| US20230227390A1 (en) | 2023-07-20 |
| US20230225985A1 (en) | 2023-07-20 |
| GB202410277D0 (en) | 2024-08-28 |
| US12552733B2 (en) | 2026-02-17 |
| GB2628746A (en) | 2024-10-02 |
| GB2609814B (en) | 2024-08-28 |
| GB202104690D0 (en) | 2021-05-12 |
| JP2023520794A (ja) | 2023-05-19 |
| GB202215746D0 (en) | 2022-12-07 |
| BR112022019616A2 (pt) | 2022-12-06 |
| KR20230121960A (ko) | 2023-08-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7727733B2 (ja) | 薬学的活性化合物としてのカンナビノイド誘導体及びその調製方法 | |
| US20240238218A1 (en) | Resorcinol derivative as a pharmaceutically active compound and method of preparation thereof | |
| KR20230122083A (ko) | 약제학적 활성 화합물로서 칸나비노이드 유도체 및이의 제조 방법 | |
| TWI451870B (zh) | 脂肪酸醯胺水解酶抑制劑 | |
| WO2022238700A1 (en) | Derivatives of cannabidiol-c4 for the treatment of epilepsy | |
| AU733264B2 (en) | Aminotetralin derivatives and compositions and method of use thereof | |
| JP2023520794A (ja) | テルペンフェノール化合物およびそれらの使用 | |
| RU2413715C2 (ru) | Способ получения замещенных тетрафторбензиланилиновых соединений и их фармацевтически приемлемых солей | |
| KR20210071949A (ko) | 신경학적 질환 또는 미트콘드리아 질환 치료용 화합물 | |
| US20040014992A1 (en) | Compounds with high monoamine transporter affinity | |
| TW201738245A (zh) | 具有抗癌活性之嘌呤化合物 | |
| CN109415285B (zh) | 苯双酚衍生物及其制备方法和在医药上的应用 | |
| Duncan et al. | 2-(. omega.-Aminoalkyl)-4-tert-butyl-6-phenylphenols as antimalarial agents | |
| WO2025255358A1 (en) | Solid forms of posiphen d-tartrate and processes of preparation thereof | |
| van Aken | Aliphatic nitro compounds in stereoselective synthesis: the development of a chiral catalyst |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221003 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240401 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240401 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20241213 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20250312 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250609 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250617 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250716 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7714571 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |